Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells February 18, 2022November 19, 2019 by admin
Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII February 18, 2022November 14, 2019 by admin
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease February 18, 2022October 10, 2019 by admin
Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A February 18, 2022October 10, 2018 by admin
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease February 18, 2022April 20, 2018 by admin
Target-Cell-Directed Bioengineering Approaches for Gene Therapy of Hemophilia A February 18, 2022January 1, 2018 by admin
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis February 18, 2022July 11, 2017 by admin
Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery February 18, 2022August 14, 2014 by admin
High Level Expression of Recombinant Porcine Coagulation Factor VIII February 18, 2022August 10, 2014 by admin
Decidual Stromal Cells Promote Regulatory T Cells and Suppress Alloreactivity in a Cell Contact-Dependent Manner February 18, 2022October 1, 2013 by admin
